Clinical Trial Update: Pharmacogenetic Study in Patients Received Iron Chelating Agent

View source ↗

Summary

A pharmacogenetic study in patients treated with an iron chelating agent for hemosiderosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemosiderosis

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hemosiderosis | Status: COMPLETED